Status:
COMPLETED
Dry Needling for Treating Spasticity in Multiple Sclerosis
Lead Sponsor:
Hospital Universitario de Canarias
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The aim of the study is to evaluate the efficacy of dry needling (DN) in the treatment of spasticity in patients with multiple sclerosis (MS). \[Participants and Methods\] participants with MS, with n...
Eligibility Criteria
Inclusion
- Being a patient diagnosed with multiple sclerosis.
- Being over 18 years of age and less than or equal to 60 years of age.
- Having a score equal to or greater than 2 in the EDSS.
- They need to have a measurement in the following functional systems: P (pyramidal) \>2, CT (brainstem), gait \>2 and sphincter \>2.
- They need to present hypertonia or contractures of the muscles selected for the dry needling, the pain expressed by the patients must be a consequence of spastic processes, have hourly availability to receive therapies and not have needle phobias.
Exclusion
- Having a disease associated with multiple sclerosis that is incompatible with dry needling.
- Being in relapse, or having suffered it in the thirty days prior to starting the treatment. program or taking medications that are contraindicated with the technique applied in the study, (oral anticoagulants.)
Key Trial Info
Start Date :
February 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 22 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05351957
Start Date
February 18 2018
End Date
September 22 2020
Last Update
April 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain, 38320